Medication Therapy Management

More Articles

Medicare Part D Pharmacy Benefit Managers Get 0.4% of Rebates

by Kelsey Waddill

After facing over $100 billion in Medicare Part D expenditures in 2016, Congress called on the Government Accountability Office to discern the pharmacy benefits manager’s (PBM’s) role in...

Targeted Medication Review Key for Medication Therapy Management

by Kelsey Waddill

A Humana study comparing the differences in medication therapy management (MTM) services found that targeted medication reviews (TMR) were highly successful interventions. “This study highlights...

PA Expands Access to Medication Assisted Treatment for SUD

by Thomas Beaton

Commercial payers and the Pennsylvania Department of Insurance (PDI) have agreed to increase access to medication-assisted treatments (MAT) and realign prior authorization processes for beneficiaries...

How Payers Can Develop a Medication Therapy Management Program

by Thomas Beaton

As the cost of medication non-adherence reaches over $300 billion annually, payers are increasingly challenged to provide new solutions to address the healthcare and economic impacts of non-adherence....

11 Healthcare Payers to Enhance Substance Use Treatment Access

by Thomas Beaton

Executives from 11 healthcare payers have pledged to enhance substance use disorder (SUD) treatment access and offer provider incentives to more effectively address opioid misuse and other substance...

Does Tiered Cost-Sharing Promote Appropriate Medication Use?

by Jacqueline LaPointe

Health plans have traditionally used tiered formulary cost-sharing arrangements to reduce healthcare spending and incentivize appropriate medication use. But a recent Journal of Managed Care &...